James M. Markert

12.3k citations
201 papers · 9.3k · 2 hit papers · h-index 50

Impact in

  • Genetics top 0.1%
    • Virus-based gene therapy research
    • Glioma Diagnosis and Treatment
  • Oncology top 0.5%
    • CAR-T cell therapy research

Papers in

    • Virus-based gene therapy research 86
    • Glioma Diagnosis and Treatment 39
    • Herpesvirus Infections and Treatments 53
    • Cytomegalovirus and herpesvirus research 17

James M. Markert

193 papers receiving 9.0k citations

James M. Markert's Hit Papers

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial 2000 · 847 citations
8470+11+23Years since publication250500750

Peers

James M. Markert
Comparison fields: 5 of 129
  • Genetics 4.9k
  • Oncology 3.4k
  • Genetics 1.3k
  • Epidemiology 2.0k
  • Biotechnology 543
Replace Tomoki Todo with:
Tomoki Todo Japan
Hiroaki Wakimoto United States
Robert L. Martuza United States
Evelin Schröck Germany
E. Antonio Chiocca United States
Yasushi Ino Japan
Brenda L. Gallie Canada
Kenneth W. Culver United States
Claudio Bordignon Italy
Boris Fehse Germany
James M. Markert relative to Tomoki Todo Japan Tomoki Todo's profile →
Citations per field
00.5×1.7×
Tomoki Todo · 1×
Citations per year

Countries citing papers authored by James M. Markert

Since Specialization
Citations

This map shows the geographic impact of James M. Markert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Markert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Markert more than expected).

Fields of papers citing papers by James M. Markert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Markert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Markert. The network helps show where James M. Markert may publish in the future.

Co-authors

The 25 scholars most cited alongside James M. Markert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James M. Markert Line = papers co-authored together James M. Markert links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 201 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
Hit paper breakdown →
1991861
2
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
Hit paper breakdown →
2000847
3 2004352
4 2008335
5 2000293
6 2014260
7 2008237
8 2001198
9 2014157
10 2010154
11 2008145
12 1996143
13 1993141
14 2012136
15 2016136
16 2014129
17 2003126
18 2014114
19 2017111
20 2005109

About James M. Markert

James M. Markert is a scholar working on Genetics, Epidemiology, Oncology, Molecular Biology and Genetics, having authored 201 papers that have together received 9.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (86 papers), Herpesvirus Infections and Treatments (53 papers), CAR-T cell therapy research (48 papers), Glioma Diagnosis and Treatment (39 papers), Brain Metastases and Treatment (21 papers), Immunotherapy and Immune Responses (17 papers), Cytomegalovirus and herpesvirus research (17 papers) and RNA Interference and Gene Delivery (16 papers). The work is most often cited by research in Genetics (4.9k citations), Oncology (3.4k citations), Genetics (1.3k citations), Epidemiology (2.0k citations) and Biotechnology (543 citations). James M. Markert has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include G. Yancey Gillespie, Amy Malick, Robert L. Martuza, Donald M. Coen, Richard J. Whitley, Katherine Ruffner, Cheryl A. Palmer, Jacqueline N. Parker, John B. Fiveash and Gregory K. Friedman. Their work appears in journals such as Journal of Neuro-Oncology, Neuro-Oncology, Neurosurgery, International Journal of Radiation Oncology*Biology*Physics and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact